TrialThe Journal of clinical investigation2001

Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients.

R Stratton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.